Clinical Trial Update: Long Term Study of the Safety of OXC XR as in Pediatric Epilepsy Subjects

View source ↗

Summary

OXC XR has been approved for marketing for pediatric epilepsy based on a long-term safety study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• OXC XR (oxcarbazepine extended-release)

Snippet

Sponsor: Supernus Pharmaceuticals, Inc. | Conditions: Epilepsy | Status: APPROVED_FOR_MARKETING